Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach, Gebunden
Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach
(soweit verfügbar beim Lieferanten)
- Herausgeber:
- Nima Rezaei
- Verlag:
- Springer, 01/2026
- Einband:
- Gebunden
- Sprache:
- Englisch
- ISBN-13:
- 9783032144003
- Artikelnummer:
- 12606474
- Umfang:
- 696 Seiten
- Gewicht:
- 1195 g
- Maße:
- 241 x 160 mm
- Stärke:
- 43 mm
- Erscheinungstermin:
- 3.1.2026
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
Telomere, DNA Damage Response, and Nanomedicine: A Triad for Cancer Treatment Innovation.- Precision Oncology: A Method to Maximize Quality of Life.- Interdisciplinary pathways for cancer treatment.- Advanced targeting systems for tissue-specific drug delivery.- New-Generation Drug Delivery Systems (DDSs) in Anticancer Strategies: Impact of Autophagy and Its Modulation.- Targeting Inflammatory Proteins for Inhibition of Cell Proliferation in Tumor Microenvironment.- Small RNAs in Cancer Therapy.- The dynamic interplay of immune cells, tumor cells, and miRNAs is a crucial focus in the search for new therapeutic targets.- Controlled Delivery of Target-Specific MicroRNA Analogs as a Key to RNAi Therapeutics in Cancer.- RNA Modifications as a Therapeutic Target in Gastrointestinal Cancer: Exploring Emerging Opportunities.- Implementing CRISPR/Cas9 into the study of anticancer drug resistance.- Microbiota Genomics and Cancer: Potential Role in Prediction as Tumor Markers, Diagnosis, and Response to Treatment.- Fighting cancer using selective antagonists targeting the substance P/neurokinin-1 receptor system.- Chronobiologically Targeted Anticancer Strategy: Synergistic Inhibition of CD39 and CD73 with Adenosine Receptor Agonists.- The sweet and sour of glycan targeting in cancer.- Lectin-based targeted drug delivery systems for the treatment of cancer.- PROTAC as an Innovative Drug Discovery Strategy for Cancer Treatment.- Dihydrofolate reductase inhibitors as anticancer agents: progress and perspectives in drug design and development.- PARP1: Opportunities of Developing New Drugs for an Old Target.- Therapeutic targeting of ATR in cancer.- RUVBL1 / 2 Complex in Cancer: Emerging Mechanisms and Therapeutic Opportunities.- Advances in Metal-Based Compounds as Emerging Therapeutics for Cancer Treatment.- New targets for cancer pain relief.- Computational Advancements and In Vitro Evaluation in Pre-Clinical Anticancer Drug Discovery and Development.